Evoclin FDA Approval History
FDA Approved: Yes (First approved October 22, 2004)
Brand name: Evoclin
Generic name: clindamycin phosphate
Dosage form: Foam
Previous Name: Actiza
Company: Connetics Corporation
Treatment for: Acne
Evoclin (clindamycin) is a topical antibiotic indicated for the treatment of acne vulgaris.
Development timeline for Evoclin
| Date | Article |
|---|---|
| Oct 22, 2004 | Approval Evoclin Connetics Corporation - Treatment for Acne |
| Mar 4, 2004 | Connetics' New Drug Application for Actiza Has Been Accepted For Filing by the FDA |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.